These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms. Leone F, Morandotti MG, Mazzella P, Sanna A, Ravizzola G, Colombrita D, Pinzi G, Turano R, Menozzi MG, Lecchini R. J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834 [Abstract] [Full Text] [Related]
5. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin. Heizmann W, Heilmann F, Werner H. Infection; 1987; 15(5):370-4. PubMed ID: 3692611 [Abstract] [Full Text] [Related]
6. Antibiotic resistance in Australia with special reference to sulbactam/ampicillin. Fernandes CJ, Ackerman VP. Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):153S-157S. PubMed ID: 2591174 [Abstract] [Full Text] [Related]
8. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes. Schumacher U, Manncke B, Gerbracht K, Werner H. Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523 [Abstract] [Full Text] [Related]
15. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections. Heizmann WR, Heilmann F, Egeler B, Werner H. Infection; 1990 Jul; 18(2):117-21. PubMed ID: 2332245 [Abstract] [Full Text] [Related]